DNA-encoded monoclonal antibody (Inovio/The Wistar Institute)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameDNA-encoded monoclonal antibody (Inovio/The Wistar Institute)
Drug Alias NameDMAb (Inovio/The Wistar Institute)cancer immunotherapy (Inovio/The Wistar Institute)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Antigen > Tumor antigen
Mechanisms of ActionProstate-specific antigen modulators
TargetsProstate-specific antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncThe Wistar Institute Of Anatomy And Biology
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A